 ENGLEWOOD, Colo., June 11, 2021 PRNewswire -- Ampio Pharmaceuticals NYSE American: AMPE, a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that management will participate in a series of one-on-one meetings with institutional investors throughout the day at the Alliance Global Partners Virtual Summer Healthcare Symposium on June 17, 2021. 